Medication Copayment 2026: What Changes and How Much You'll Pay with Public Prescription

Key data

Medication copayment changes in Spain as of May 12, 2026. The Royal Decree-Law 11/2026 modifies the economic contribution made by users of the public health system when withdrawing medications at the pharmacy with a prescription. As it is approved as a decree-law, it has immediate effect: it does not require prior parliamentary processing and is already in force.

The change directly affects the pockets of millions of citizens and requires pharmacies and health managers to update their operating systems without delay.

What does this regulation establish?

RDL 11/2026 modifies the outpatient pharmaceutical provision system, that is, the copayment for medications dispensed in pharmacy offices with a public health system prescription. The elements of the system that are modified are:

• Contribution brackets by income: The percentages or amounts that each user pays based on their income level are modified.
• Exempt groups: Which population groups are totally or partially exempt from contribution are reviewed.
• Maximum monthly spending caps: The maximum limits that a user can pay per month for medications with public prescription are updated.

The regulation applies exclusively to outpatient pharmaceutical provision: medications dispensed in pharmacies with a public system prescription. It does not affect hospital medications dispensed at the health facility itself.

As it is a Royal Decree-Law, the Government has used the urgent procedure to approve this reform, which means it came into force on the same day of its approval, May 12, 2026, one day before its publication in the BOE.

Economic and operational impact

This reform has a dual economic impact: on public pharmaceutical spending and on direct citizen spending.

The groups with the greatest economic exposure are chronic patients, who withdraw medications continuously, pensioners and people with low incomes. For these groups, any variation in brackets or monthly caps has a direct and recurring impact on their household economy.

For pharmacies, the impact is mainly operational: they must ensure that their systems correctly apply the new parameters from May 12, 2026, without a transition period.

Who does it affect?

• Patients with public prescription: Any person who withdraws medications at a pharmacy with a public health system prescription will see their contribution modified according to the new brackets.
• Pensioners: A group particularly sensitive to changes in brackets and monthly caps, given the usual volume of medication.
• People with chronic diseases: Affected recurrently by any modification in monthly maximum caps and contribution percentages.
• People with low incomes: Changes in contribution brackets by income may modify their copayment percentage or their exempt status.
• Pharmacies: Required to immediately adapt their billing and dispensing systems to correctly apply the new regulation.
• Health managers: Responsible for updating the information systems of the public health system.

Practical example

A patient with a chronic disease who withdraws several medications per month with a public prescription is directly affected by this reform as of May 12, 2026.

If their income level places them in a bracket modified by RDL 11/2026, the percentage they pay for each medication changes automatically. If there was also a maximum monthly cap that has been revised, the maximum amount they can pay per month also varies.

For its part, a pharmacy serving this patient must have its systems updated as of May 12 to apply the correct bracket at the time of dispensing. If the system is not updated, there is a risk of charging an incorrect amount, which can generate complaints and billing problems with the public system.

To find out the exact amounts for each bracket and the new monthly caps, it is necessary to consult the full text of RDL 11/2026 in the BOE.

What should companies do now?

1. Pharmacies: update billing and dispensing systems to apply the new contribution brackets, exemptions and maximum caps from May 12, 2026. There is no transition period.
2. Health managers: review information systems of the public health system to ensure that each user's contribution data is correctly updated.
3. Patients and beneficiaries: check the new bracket assigned according to their income level to know the copayment percentage that applies to them and the applicable maximum monthly cap.
4. Companies with health services or social benefits for employees: assess whether changes in public copayment have an impact on the conditions of supplementary insurance or benefits offered.
5. Consult the official text in the BOE (BOE-A-2026-10324) to verify the exact amounts for each bracket and the new monthly caps, as these are the binding data.